P. Dellabona

Deciphering the immunological determinants of response to neoadjuvant chemo-radiation in esophageal adenocarcinoma

Background The standard therapy for esophageal adenocarcinoma (EAC) is pre-operative neoadjuvant chemo-radiation (NACR) and surgery. Less than 30% of patients achieve a ...

G. Arbore ;

L. Albarello ;

G. Bucci ;

M. Punta ;

V. Bilello ;

L. Fanti ;

A. Cossu ;

G. Tonon ;

G. Casorati ;

P. Dellabona ;

Riccardo Rosati , MD;

06/28/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

P. Dellabona

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products